Publikasjoner ved seksjon for onkologi 2010

 

 

Identification and characterization of retinoblastoma gene mutations disturbing apoptosis in human breast cancers.

Berge EO, Knappskog S, Geisler S, Staalesen V, Pacal M, Børresen-Dale AL, Puntervoll P, Lillehaug JR, Lønning PE.

Mol Cancer. 2010 Jul 1;9:173.PMID: 20594292 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text

 

Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity.

Berge EO, Staalesen V, Straume AH, Lillehaug JR, Lønning PE.

Biochim Biophys Acta. 2010 Mar;1803(3):386-95. Epub 2010 Jan 15.PMID: 20080130 [PubMed - indexed for MEDLINE]

 

Competition and quality in health care markets: a differential-game approach.

Brekke KR, Cellini R, Siciliani L, Straume OR.

J Health Econ. 2010 Jul;29(4):508-23. Epub 2010 Jun 12.PMID: 20542342 [PubMed - indexed for MEDLINE]

 

 

Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.

Brydøy M, Fosså SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T, Dahl O; Norwegian Urology Cancer Group III study group.

Eur Urol. 2010 Jul;58(1):134-40. Epub 2010 Apr 2.PMID: 20395037 [PubMed - indexed for MEDLINE]

 

 

AMGMT expression levels predict disease stabilisation, progression-free and overall survival in patients with advanced melanomas treated with DTIC.

Busch C, Geisler J, Lillehaug JR, Lønning PE.

Eur J Cancer. 2010 Jul;46(11):2127-33. Epub 2010 Jun 10.PMID: 20541396 [PubMed - indexed for MEDLINE]Related citations

 

Alterations in the p53 pathway and p16INK4a expression predict overall survival in metastatic melanoma patients treated with dacarbazine.

Busch C, Geisler J, Knappskog S, Lillehaug JR, Lønning PE.

J Invest Dermatol. 2010 Oct;130(10):2514-6. Epub 2010 May 27. No abstract available. PMID: 20505745 [PubMed - indexed for MEDLINE]

 

Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium.

Christensen K, Aaberg-Jessen C, Andersen C, Goplen D, Bjerkvig R, Kristensen BW.

Neurosurgery. 2010 May;66(5):933-47. PMID: 20404698 [PubMed - indexed for MEDLINE]

 

A controlled study of risk factors for disease and current problems in long-term testicular cancer survivors.

Dahl CF, Haugnes HS, Bremnes R, Dahl O, Fosså SD, Klepp O, Wist E, Dahl AA.

J Cancer Surviv. 2010 Sep;4(3):256-65. Epub 2010 Jun 24.PMID: 20574815 [PubMed - indexed for MEDLINE]

 

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response.

Dejeux E, Rønneberg JA, Solvang H, Bukholm I, Geisler S, Aas T, Gut IG, Børresen-Dale AL, Lønning PE, Kristensen VN, Tost J.

Mol Cancer. 2010 Mar 25;9:68.PMID: 20338046 [PubMed - indexed for MEDLINE]Free PMC ArticleFree text

 

 

Impact of aromatase inhibitors on bone health in breast cancer patients.

Geisler J, Lønning PE.

J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):294-9. Epub 2009 Oct 13.PMID: 19833206 [PubMed - indexed for MEDLINE]

 

Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.

Geisler J, Suzuki T, Helle H, Miki Y, Nagasaki S, Duong NK, Ekse D, Aas T, Evans DB, Lønning PE, Sasano H.

J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):237-41. Epub 2009 Oct 31.PMID: 19883757 [PubMed - indexed for MEDLINE]

 

αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells.

Goplen D, Bougnaud S, Rajcevic U, Bøe SO, Skaftnesmo KO, Voges J, Enger PØ, Wang J, Tysnes BB, Laerum OD, Niclou S, Bjerkvig R.

Am J Pathol. 2010 Oct;177(4):1618-28. Epub 2010 Sep 2. PMID: 20813964 [PubMed - indexed for MEDLINE]

 

 

Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.

Haugnes HS, Wethal T, Aass N, Dahl O, Klepp O, Langberg CW, Wilsgaard T, Bremnes RM, Fosså SD.

J Clin Oncol. 2010 Oct 20;28(30):4649-57. Epub 2010 Sep 20.PMID: 20855830 [PubMed - indexed for MEDLINE]

Intratumoral estrogen disposition in breast cancer.

Haynes BP, Straume AH, Geisler J, A'Hern R, Helle H, Smith IE, Lønning PE, Dowsett M.

Clin Cancer Res. 2010 Mar 15;16(6):1790-801. Epub 2010 Mar 9.PMID: 20215536 [PubMed - indexed for MEDLINE]

 

High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.

Hurmuzlu M, Monge OR, Smaaland R, Viste A.

Dis Esophagus. 2010 Apr;23(3):244-52. Epub 2009 Jul 31.PMID:19664075[PubMed - indexed for MEDLINE]

 

High-dose chemoradiotherapy followed by surgery versus surgery alone in esophageal cancer: a retrospective cohort study.

Hurmuzlu M, Øvrebø K, Monge OR, Smaaland R, Wentzel-Larsen T, Viste A.

World J Surg Oncol. 2010 Jun 1;8:46. PMID:20515502[PubMed - indexed for MEDLINE] Free PMC ArticleFree full text

 

Cellular effects of oncolytic viral therapy on the glioblastoma microenvironment.

Huszthy PC, Immervoll H, Wang J, Goplen D, Miletic H, Eide GE, Bjerkvig R.

Gene Ther. 2010 Feb;17(2):202-16. Epub 2009 Oct 15. PMID:19829315 [PubMed - indexed for MEDLINE]

 

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.

Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P; European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); European Society for Hyperthermic Oncology (ESHO).

Lancet Oncol. 2010 Jun;11(6):561-70. Epub 2010 Apr 29. PMID: 20434400 [PubMed - indexed for MEDLINE]

 

 

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.

Janson ET, Sørbye H, Welin S, Federspiel B, Grønbaek H, Hellman P, Mathisen O, Mortensen J, Sundin A, Thiis-Evensen E, Välimäki MJ, Oberg K, Knigge U.

Acta Oncol. 2010 Aug;49(6):740-56. Review.PMID:20553100[PubMed - indexed for MEDLINE

 

Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007.

Kvåle R, Møller B, Angelsen A, Dahl O, Fosså SD, Halvorsen OJ, Hoem L, Solberg A, Wahlqvist R, Bray F.

Cancer Epidemiol. 2010 Aug;34(4):359-67. Epub 2010 Jun 2.PMID: 20627840 [PubMed - indexed for MEDLINE]

 

Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy.

International Prognostic Factors Study Group, Lorch A, Beyer J, Bascoul-Mollevi C, Kramar A, Einhorn LH, Necchi A, Massard C, De Giorgi U, Fléchon A, Margolin KA, Lotz JP, Germa Lluch JR, Powles T, Kollmannsberger CK.

J Clin Oncol. 2010 Nov 20;28(33):4906-11. Epub 2010 Oct 18.PMID: 20956623 [PubMed - indexed for MEDLINE]

 

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.

Jönsson G, Busch C, Knappskog S, Geisler J, Miletic H, Ringnér M, Lillehaug JR, Borg A, Lønning PE.

Clin Cancer Res. 2010 Jul 1;16(13):3356-67. Epub 2010 May 11.PMID: 20460471 [PubMed - indexed for MEDLINE]

 

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.

Ladstein RG, Bachmann IM, Straume O, Akslen LA.

BMC Cancer. 2010 Apr 14;10:140. PMID:20398247[PubMed - indexed for MEDLINE] Free PMC Article

 

 

Alternative cyclin D1 splice forms differentially regulate the DNA damage response.

Li Z, Jiao X, Wang C, Shirley LA, Elsaleh H, Dahl O, Wang M, Soutoglou E, Knudsen ES, Pestell RG.

Cancer Res. 2010 Nov 1;70(21):8802-11. Epub 2010 Oct 12.PMID: 20940395 [PubMed - indexed for MEDLINE]

 

Molecular basis for therapy resistance.

Lønning PE.

Mol Oncol. 2010 Jun;4(3):284-300. Epub 2010 Apr 24. Review.PMID: 20466604 [PubMed - indexed for MEDLINE]

 

Evolution of endocrine adjuvant therapy for early breast cancer.

Lønning PE.

Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S19-30. Review.PMID: 20374026 [PubMed - indexed for MEDLINE]

 

The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum.

Lønning PE.

Ann Oncol. 2010 Jul 8. [Epub ahead of print]PMID: 20616198 [PubMed - as supplied by publisher]

 

Are current development programs realising the full potential of new agents?

Lønning PE.

Breast Cancer Res. 2010 Dec 20;12 Suppl 4:S23. No abstract available. PMID: 21172086 [PubMed - in process]Free PMC ArticleFree text

 

Endocrine effects of aromatase inhibitors.

Lønning PE, Dowsett M.

J Clin Oncol. 2010 Feb 20;28(6):e101-2; author reply e103-4. Epub 2010 Jan 19. No abstract available. PMID: 20085930 [PubMed - indexed for MEDLINE]

 

Evaluation of plasma and tissue estrogen suppression with third-generation aromatase inhibitors: of relevance to clinical understanding?

Lønning PE, Geisler J.

J Steroid Biochem Mol Biol. 2010 Feb 28;118(4-5):288-93. Epub 2009 Oct 4.PMID: 19808096 [PubMed - indexed for MEDLINE]

 

Fibroblast Growth Factor 2-A Predictor of Outcome for Patients Irradiated for Stage II-III Non-Small-Cell Lung Cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F.

Int J Radiat Oncol Biol Phys. 2010 Oct 14. [Epub ahead of print]PMID: 20950963 [PubMed - as supplied by publisher]

 

Prognostic Impact of Erythropoietin Expression and Erythropoietin Receptor Expression on Locoregional Control and Survival of Patients Irradiated for Stage II/III Non-Small-Cell Lung Cancer.

Rades D, Setter C, Dahl O, Schild SE, Noack F.

Int J Radiat Oncol Biol Phys. 2010 Jun 18. [Epub ahead of print]PMID: 20646855 [PubMed - as supplied by publisher]

 

Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC).

Rades D, Setter C, Dunst J, Dahl O, Schild SE, Noack F.

Strahlenther Onkol. 2010 Jun;186(6):307-14. Epub 2010 Apr 26.PMID: 20437013 [PubMed - indexed for MEDLINE]

 

 

Session 6 introduction.

Robertson JF, Lønning PE.

Breast Cancer Res. 2010 Dec 20;12 Suppl 4:S15. No abstract available. PMID: 21172077 [PubMed - in process]Free PMC ArticleFree text

 

A study of coping in long-term testicular cancer survivors.

Rutskij R, Gaarden T, Bremnes R, Dahl O, Finset A, Fossa SD, Klepp O, Sorebo O, Wist E, Dahl AA.

Psychol Health Med. 2010 Mar;15(2):146-58.PMID: 20391232 [PubMed - indexed for MEDLINE]

 

Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.

Tandstad T, Cohn-Cedermark G, Dahl O, Stierner U, Cavallin-Stahl E, Bremnes RM, Klepp O.

Ann Oncol. 2010 Sep;21(9):1858-63. Epub 2010 Feb 8.PMID: 20142410 [PubMed - indexed for MEDLINE]

 

Rectum motion and morbidity prediction: Improving correlation between late morbidity and DVH parameters through use of rectum planning organ at risk volumes.

Thor M, Væth M, Karlsdottir A, Muren LP.

Acta Oncol. 2010 Oct;49(7):1061-8. PMID: 20831497 [PubMed - indexed for MEDLINE]

 

 

Cognitive dysfunction and health-related quality of life after a cardiac arrest and therapeutic hypothermia.

Torgersen J, Strand K, Bjelland TW, Klepstad P, Kvåle R, Søreide E, Wentzel-Larsen T, Flaatten H.Acta Anaesthesiol Scand. 2010 Jul;54(6):721-8. Epub 2010 Mar 10.

PMID:20236101 [PubMed - indexed for MEDLINE

 

 

Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter.

Torsvik A, Røsland GV, Svendsen A, Molven A, Immervoll H, McCormack E, Lønning PE, Primon M, Sobala E, Tonn JC, Goldbrunner R, Schichor C, Mysliwietz J, Lah TT, Motaln H, Knappskog S, Bjerkvig R.

Cancer Res. 2010 Aug 1;70(15):6393-6. Epub 2010 Jul 14. No abstract available. PMID: 20631079 [PubMed - indexed for MEDLINE]